Mu Opioid Receptor
Mu Opioid Receptor - Related Videos
01:22
Opioid Receptors: Overview
0 Views •
2024
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:15
Opioid Analgesics: Synthetic and Semisynthetic Opioids
0 Views •
2024
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:17
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
0 Views •
2024
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated. Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
07:48
Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
0 Views •
Cited by 1 •
2015
Receptor trafficking modulates signaling and cell responsiveness to ligands and is, itself, responsive to cell conditions, including ligand-induced signaling. Here, we describe a powerful and flexible technique for quantitatively assessing drug-induced receptor trafficking using immunolabeling and colocalizational analysis.
01:20
Opioid Analgesics: Morphine and Other Natural Cogeners
0 Views •
2024
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
FAQs
Gi/o coupling converts receptor activation into inhibitory intracellular signaling. It reduces adenylyl cyclase activity, which changes downstream signaling, while also limiting presynaptic calcium entry and increasing potassium conductance. Together, these effects reduce neuronal excitability and neurotransmitter release. This signaling pattern explains why MOR activation can suppress pain-related neural communication.
The two ion-channel effects suppress neuronal communication through complementary mechanisms. Reduced presynaptic calcium influx limits the release of neurotransmitters, while increased potassium conductance makes neurons less excitable. Their combined action decreases both chemical signaling between neurons and the likelihood of neuronal activation, helping account for the receptor's inhibitory effects in pain pharmacology.
MOR activation influences neuronal signaling broadly rather than producing analgesia alone. The same inhibitory signaling associated with reduced pain transmission is linked with sedation, respiratory depression, constipation, reward, tolerance, and physical dependence. Pharmacology therefore evaluates receptor activation as a balance between desired pain relief and adverse or adaptive responses that can limit treatment utility.
Researchers examine how MOR signaling relates to the effects produced by opioid medications and endogenous opioid peptides. Analgesia reflects a desired pharmacological outcome, whereas sedation, respiratory depression, constipation, reward, tolerance, and physical dependence indicate additional consequences. Linking receptor signaling with this range of outcomes helps clarify opioid efficacy and its limitations.
A broad assessment should include both therapeutic and adverse outcomes. Pain relief indicates analgesic activity, while sedation, respiratory depression, constipation, reward, tolerance, and physical dependence reveal other effects associated with MOR activation. Considering these outcomes together provides a more complete interpretation than evaluating analgesia alone and supports comparisons among opioid-based treatment strategies.
Studying MOR signaling provides a pharmacological basis for improving pain treatments while addressing opioid-related risks. Researchers can use knowledge of receptor-linked efficacy and adverse effects to guide the development of safer analgesics. The same research context also supports strategies for treating opioid use disorder, particularly by clarifying reward, tolerance, and physical dependence.